Cargando…
Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome
Patients with severe COVID-19 often experience complications including coagulopathy and fatal thrombosis. COVID-19 pneumonia sometimes leads to acute respiratory distress syndrome, requiring extracorporeal membrane oxygenation (ECMO), during which thrombosis and bleeding are major causes of death. A...
Autores principales: | Hayakawa, Masaki, Takano, Keisuke, Kayashima, Michinori, Kasahara, Kei, Fukushima, Hidetada, Matsumoto, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147570/ https://www.ncbi.nlm.nih.gov/pubmed/33116032 http://dx.doi.org/10.5551/jat.58362 |
Ejemplares similares
-
Hemolysis and von Willebrand factor degradation in mechanical shuttle shear flow tester
por: Shiraishi, Yasuyuki, et al.
Publicado: (2021) -
Acquired von Willebrand Syndrome Associated with Cardiovascular Diseases
por: Horiuchi, Hisanori, et al.
Publicado: (2019) -
von Willebrand Factor, Free Hemoglobin and Thrombosis in ECMO
por: Valladolid, Christian, et al.
Publicado: (2018) -
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study
por: Büchsel, Martin, et al.
Publicado: (2023) -
Analysis focusing on plasma von Willebrand factor in pachychoroid neovasculopathy and age-related macular degeneration
por: Hirai, Hiromasa, et al.
Publicado: (2021)